Depomed cutting one-fourth of staff

Menlo Park-based pharmaceutical firm Depomed Inc. (DEPO), is making staff cuts affecting approximately one-fourth of its staff following disappointing results in a phase 3 study in postherpetic neuralgia.

The company has two products on the market and other candidates in its development pipelines and holds proprietary drug delivery technology for the improvement of oral medications.

If you find our journalism valuable and relevant, please consider joining our Examiner membership program.
Find out more at www.sfexaminer.com/join/

Just Posted

Homeless sweep leads to few shelter placements

City officials report that the removal of a large homeless encampment from… Continue reading

Shoe guru John Fluevog celebrates 50 years

Designer’s new book is ‘Unique Soles for Unique Souls’

Man injured in SF police shooting suspected of assault, battery

DA has yet to file formal charges against Jamaica Hampton, 24

It’s official: SF e-scooter company workers vote to unionize, a first

San Francisco e-scooter company Spin may be the first in the nation… Continue reading

Muni lobbies for funding to buy more trains after fixing problems with first batch

Muni’s $1.1 billion new train fleet debuted with multiple problems — but… Continue reading

Most Read